In a landmark randomized, double-blind controlled clinical trial, Crescel delivered dramatically superior results versus standard prescription rosacea therapy — reducing redness by 54% vs. 23% and inflammatory lesions by 74% vs. 17%. Crescel achieved statistically significant improvements across all key clinical measures with no reported adverse effects or irritation, signaling a breakthrough in rosacea treatment. 

"Efficacy, Tolerance, and Safety of a Novel Botanical Anti-Inflammatory Moisturizer in Rosacea: Results From a Double-Blinded, Randomized Controlled Trial"

Please review the following peer-reviewed medical journal publications detailing Crescel’s landmark randomized controlled rosacea clinical trial, authored by a world-renowned dermatologist and published in internationally recognized medical journals.

https://onlinelibrary.wiley.com/doi/10.1111/jocd.70910
https://pubmed.ncbi.nlm.nih.gov/42163060/